Nathan Rice
Stock Analyst at Piper Sandler
(3.00)
# 1,359
Out of 5,116 analysts
61
Total ratings
52.63%
Success rate
9.93%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $139.50 | +7.53% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $42.03 | +14.20% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $41.46 | +1.30% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $31.93 | +9.61% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $74.52 | -0.70% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $145.98 | -42.46% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $163.03 | +20.84% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $24.08 | -62.62% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $670.46 | -35.12% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $274.11 | -15.00% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $43.32 | +91.60% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.84 | -24.40% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $139.50
Upside: +7.53%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $42.03
Upside: +14.20%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $41.46
Upside: +1.30%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $31.93
Upside: +9.61%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $74.52
Upside: -0.70%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $145.98
Upside: -42.46%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $163.03
Upside: +20.84%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $24.08
Upside: -62.62%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $670.46
Upside: -35.12%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $274.11
Upside: -15.00%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $43.32
Upside: +91.60%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.84
Upside: -24.40%